Condition: Gout · Sponsor: Assistance Publique - Hôpitaux de Paris
Gout is the most frequent inflammatory arthritis in men after 40 years, with a prevalence of 0.9% in France. This disease is characterized by deposits of sodium urate crystals in joints, tendons and soft tissues, which can be detected by ultrasound examination. To date, there was no study assessing inflammatory, structural and deposit lesions due to gout in joints and tendons, since the standardization of ultrasound definitions of gout by the OMERACT (Outcome Measures in Rheumatology) in 2015. The objective of this study is t estimate the prevalence and severity of ultrasound inflammatory lesions (synovitis, tenosynovitis, soft tissues abnormalities), structural lesions (osteophytes, erosions) and abnormalities due to sodium urate deposits (double contour, aggregates, tophi) in patients with gout.
This description comes directly from the study's public registry record.
Maria-Antonietta D'AGOSTINO, MD, PhD · +33 01 49 09 56 74 · maria-antonietta.dagostino@aphp.fr
Hélène Gouze, MD · +33149094674 · helene.gouze@aphp.fr
Always discuss trial participation with your own doctor first.
| Rhumatology department, Ambroise Paré hospital - APHP | Boulogne-Billancourt, APHP, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05546593